Nuveen Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-18,325
| Closed | -$202K | – | 3431 |
|
|
2022
Q1 | $202K | Buy |
18,325
+266
| +1% | +$2.93K | ﹤0.01% | 3192 |
|
|
2021
Q4 | $611K | Sell |
18,059
-1,799
| -9% | -$60.9K | ﹤0.01% | 3016 |
|
|
2021
Q3 | $1.01M | Buy |
19,858
+1,807
| +10% | +$91.8K | ﹤0.01% | 2985 |
|
|
2021
Q2 | $984K | Buy |
18,051
+3,390
| +23% | +$185K | ﹤0.01% | 3013 |
|
|
2021
Q1 | $1.1M | Buy |
14,661
+220
| +2% | +$16.4K | ﹤0.01% | 2858 |
|
|
2020
Q4 | $1.57M | Sell |
14,441
-3,675
| -20% | -$399K | ﹤0.01% | 2627 |
|
|
2020
Q3 | $1.6M | Sell |
18,116
-2,213
| -11% | -$196K | ﹤0.01% | 2478 |
|
|
2020
Q2 | $2.17M | Buy |
20,329
+6,466
| +47% | +$689K | ﹤0.01% | 2313 |
|
|
2020
Q1 | $822K | Sell |
13,863
-200
| -1% | -$11.9K | ﹤0.01% | 2597 |
|
|
2019
Q4 | $972K | Buy |
14,063
+3,299
| +31% | +$228K | ﹤0.01% | 2698 |
|
|
2019
Q3 | $1.12M | Sell |
10,764
-436
| -4% | -$45.2K | ﹤0.01% | 2653 |
|
|
2019
Q2 | $1.04M | Buy |
+11,200
| New | +$1.04M | ﹤0.01% | 2721 |
|